SCHEMBL411987

SCHEMBL411987

CCOc1c(-c2ccc(C)c(Cl)c2)cc(CO)nc1Cl

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KMO O15229 2/20 0.37
PTGS2 P35354 2/20 0.35
PTGS1 P23219 1/20 0.34
DHODH Q02127 3/20 0.34
TRPV1 Q8NER1 1/20 0.34
KCNH2 Q12809 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
S1PR4 O95977 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL443355 0.85 APP (0.37) KMOPTGS2PTGS1CYP1A2CYP3A4
SCHEMBL412279 0.85 KMT2A (0.43) KDM4EALDH1A1HPGDTDP1S1PR1
SCHEMBL15715813 0.80 S1PR1 (0.40) KMOPTGS2PTGS1KCNH2KDM4E
SCHEMBL29423329 0.72 CNR1 (0.42) KMOTRPV1
SCHEMBL20594055 0.72 CNR1 (0.42) KMOTRPV1
SCHEMBL9973788 0.70 THRB (0.45) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL411440 0.70 BPTF (0.37) KDM4EALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL463741 0.68 RORC (0.39) PTGS2KCNH2KDM4EALDH1A1S1PR4
SCHEMBL439793 0.68 DGAT1 (0.36) KMOPTGS2PTGS1CYP1A2CYP3A4
SCHEMBL411899 0.68 CNR1 (0.41) KMO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9090599-B2 Heteroarylmethyl amides HOFFMANN-LA ROCHE INC. (US) 2015-07-28 US disclosed
US-20140194436-A1 HETEROARYLMETHYL AMIDES HOFFMANN-LA ROCHE INC. (US) 2014-07-10 US disclosed
US-8729105-B2 Heteroarylmethyl amides HOFFMANN LA-ROCHE INC. (US) 2014-05-20 US disclosed
US-20120065212-A1 HETEROARYLMETHYL AMIDES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140194436-A1 HETEROARYLMETHYL AMIDES APOB, LDLR, HMGCR KMO 2423/4885PTGS2 2497/4885PTGS1 1623/4885
US-20120065212-A1 HETEROARYLMETHYL AMIDES APOB, LDLR, HMGCR KMO 2423/4885PTGS2 2497/4885PTGS1 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.